
Organoids For Neuroscience

PROBLEM
Neurodegenerative diseases, especially Alzheimers, are challenging for drug development. Real drug solutions do not yet exist. One of the major obstacles is not being able to test potential new drugs on humans during the preclinical stage. We believe that our technology is the solution.

SOLUTION
We strongly believe that our novel 4D bioprinting technology combined with stem cells will make organoid technology a necessity during preclinical
drug development.
Our Technology
01 / RELIABLE
02 / RELEVANT

Variability among organoids creates unreliable data. We offer a new 4D bioprinting technology that will bring control and consistency to organoid systems.

Two dimensional cell cultures and animal models are not physiologically representative of humans. Using actual human cells, our 4D bioprinted live organoids will be ideal to model human diseases.
03 / SCALABLE

Our new high speed, 4D bioprinting technology will revolutionize high throughput drug screening platforms for brain organoids and augment preclinical outcomes.
Product & Services

Bank of Live Organoid
Disease Models
​Genetic mutations relevant to the disease
Provided at any stage of development
​
Delivered directly to the customer's lab

Organoid Drug Development Assays
-
Order live reliable Organoids delivered to your doorstep and ready to use.
-
Order Organoids with a genetic mutation relevant to your Disease.
-
Order Organoids at any stage of their development (4 weeks to x years old )
Conduct the following test for customer specific compounds:
​
Drug Screening
​
Dose Response
​​
Toxicity Testing
Meet the Team

Renaud Schuck, Ph.D
Co-Founder | CEO
​
Neuroscientist with expertise
in optics and 4D bioprinting
Imperial College London Ph.D

Jariel Bytheway
Co-Founder | CBO
​
Corporate Strategy and Operations expertise
in Aerospace and Life Sciences
Yale MBA and UCLA Alumnus

Christopher Lovejoy, Ph.D
Organoids Specialist
​
Neuroscientist with expertise in organoids
and neurodegenerative diseases
University College London Ph.D


San Francisco, CA
Seattle, WA

